Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.

Dabholkar AH, Han C, Paris MM, Perez MC, Atkinson SN, Peura DA.

Aliment Pharmacol Ther. 2011 Feb;33(3):366-77. doi: 10.1111/j.1365-2036.2010.04519.x. Epub 2010 Nov 30.

3.

Use of proton-pump inhibitors in early pregnancy and the risk of birth defects.

Pasternak B, Hviid A.

N Engl J Med. 2010 Nov 25;363(22):2114-23. doi: 10.1056/NEJMoa1002689.

4.

Proton pump inhibitors: a better prescription is needed.

Khara HS, Pitchumoni CS.

J Clin Gastroenterol. 2009 Jul;43(6):597-8. doi: 10.1097/MCG.0b013e318194c452. No abstract available.

PMID:
19384247
5.

Omeprazole-induced cough in a patient with gastroesophageal reflux disease.

Reiche I, Tröger U, Martens-Lobenhoffer J, Kandulski A, Neumann H, Malfertheiner P, Bode-Böger SM.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):880-2. doi: 10.1097/MEG.0b013e3283320129.

PMID:
19801940
6.

Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.

Mackay JD, Bladon PT.

QJM. 2010 Jun;103(6):387-95. doi: 10.1093/qjmed/hcq021. Epub 2010 Apr 8.

PMID:
20378675
7.

Proton pump inhibitor use and enteric infections.

Dial MS.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S10-6. doi: 10.1038/ajg.2009.46. Review.

PMID:
19262540
8.

Gastroesophageal reflux disease.

Aguirre C, Ruiz-Irastorza G, Egurbide MV.

N Engl J Med. 2009 Feb 12;360(7):729; author reply 729-30. doi: 10.1056/NEJMc082292. No abstract available.

9.

Distal renal tubular acidosis that became exacerbated by proton pump inhibitor use.

Okamoto N, Nambu T, Matsuda Y, Matsuo K, Osaki K, Kanai Y, Ogawa Y, Yonemitsu S, Kita R, Muro S, Sugawara A, Oki S.

Intern Med. 2012;51(18):2591-5. Epub 2012 Sep 15.

10.

Gastroesophageal reflux disease.

Fernández-Fernández FJ.

N Engl J Med. 2009 Feb 12;360(7):729; author reply 729-30. No abstract available.

PMID:
19222130
11.

Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.

Frazzoni M, Conigliaro R, Melotti G.

Aliment Pharmacol Ther. 2011 Mar;33(5):601-6. doi: 10.1111/j.1365-2036.2010.04550.x. Epub 2010 Dec 29.

12.

Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.

Devault KR.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):197-205. doi: 10.1586/17474124.1.2.197. Review.

PMID:
19072410
13.

Unexpected consequences of proton pump inhibitor use.

Altman KW, Radosevich JA.

Otolaryngol Head Neck Surg. 2009 Nov;141(5):564-6. doi: 10.1016/j.otohns.2009.08.027.

PMID:
19861191
14.

On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.

Juul-Hansen P, Rydning A.

Aliment Pharmacol Ther. 2009 Jan;29(2):207-12. doi: 10.1111/j.1365-2036.2008.03877.x. Epub 2008 Oct 22.

15.

Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.

Hoogendoorn RJ, Groeneveld L, Kwee JA.

Clin Drug Investig. 2009;29(12):803-10. doi: 10.2165/11530810-000000000-00000.

PMID:
19888786
16.

Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?

Lee TJ, Fennerty MB, Howden CW.

Aliment Pharmacol Ther. 2004 Dec;20(11-12):1241-51. Review.

17.

[Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].

Mouterde O, Bellaïche M, Dumant C, Mallet E.

Arch Pediatr. 2010 Jun;17(6):739-40. doi: 10.1016/S0929-693X(10)70086-5. French. No abstract available.

PMID:
20654868
18.

Alternative therapeutic approaches to chronic proton pump inhibitor treatment.

Fass R.

Clin Gastroenterol Hepatol. 2012 Apr;10(4):338-45; quiz e39-40. doi: 10.1016/j.cgh.2011.12.020. Epub 2011 Dec 16. Review.

PMID:
22178462
19.

Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.

Holtmann G, Bigard MA, Malfertheiner P, Pounder R.

Int J Clin Pharm. 2011 Jun;33(3):493-500. doi: 10.1007/s11096-011-9489-y. Epub 2011 Apr 7.

PMID:
21472476
20.

Bone up on proton pump inhibitors and fracture risk.

Gendreau-Webb R.

Nursing. 2007 Oct;37(10):60-1. No abstract available.

PMID:
17906557

Supplemental Content

Support Center